Provider payments and patients charges as policy tools for cost-containment: How successful are they in high-income countries?

Human Resources for Health

Volumn 1, Issue , 2003, Pages

  Carrin, Guy ^a   Hanvoravongchai, Piya ^a,b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b Thailand Health Systems Research Institute   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0347743113     PISSN: 14784491     EISSN: None     Source Type: Journal    
DOI: 10.1186/1478-4491-1-6     Document Type: Article

References (38)

1. Gray G: Access to medical care under strain: new pressures in Canada and Australia Journal of Health Politics, Policy and Law 1998, 23(6):905-947.
2. Feldstein P: Health Care Economics Albany: Delmar Publishers 1999.
3. Rice T: The Economics of Health Reconsidered Chicago: Health Administration Press 1998.
4. Greenfield S et al.: Variations in resource utilization among medical specialties and systems of care JAMA 1992, 267(12):1624-1630.
5. Gerdtham UG and Jonsson B: International comparisons of health expenditure: theory, data and econometric analysis In Handbook of health economics Volume 1A. Edited by: Culyer AJ, Newhouse JP. Amsterdam: Elsevier; 2000:11-53.
6. Ikegami N and Campbell JC: Medical care in Japan The New England Journal of Medicine 1995, 333(19):1295-1299.
7. World Health Organization: The World Health Report 2001 Geneva 2001.
8. Ikegami N and Campbell JC: The art of balance in health policy: maintaining Japan's low-cost, egalitarian system New York: Cambridge University Press 1998.
9. Mossialos E and Le Grand J: Cost Containment in the EU: an overview In Health care and cost containment in the European Union Edited by: Mossialos E, Le Grand J. Aldershot: Ashgate Publishing Ltd; 1999:1-154.
10. Crainich D and Closon MC: Cost containment and health care reform in Belgium In Health care and cost containment in the European Union Edited by: Mossialos E, Le Grand J. Aldershot: Ashgate Publishing Ltd; 1999:219-266.
11. Barer ML, Lomas J and Sanmartin C: Re-minding our Ps and Qs: Medical cost controls in Canada Health Affairs 1996, 15(2):216-234.
12. Canada's Health Care System [http://www.hc-sc.gc.ca/]
13. European Observatory on Health Care Systems Health Care Systems in Transition: Belgium Copenhagen 2000.
14. Coulam RF and Gaumer GL: Medicare's prospective payment system: a critical appraisal Health Care Financing Review, Annual Suppl:45-77.
15. Schulenbury JM: Forming and reforming the market for third-party purchasing of health care: Social Science and Medicine 1994, 39(10):1473-81.
16. Miller M et al.: Service mix in the hospital outpatient department: implications for Medicare payment reform Health Services Research 1995, 30(1):59-77.
17. Carroll NV and Erwin WG: Patient shifting as a response to Medicare prospective payment Medical Care 1987, 25:1161-7.
18. Järvelin J: Health care systems in transition Finland: WHO, Copenhagen 2002.
19. Tabbush V and Swanson G: Changing paradigms in medical payment Archives of Internal Medicine 1996, 156:357-60.
20. Miller R and Luft H: Managed Care Performance since 1980: A literature analysis Journal of the American Medical Association 1994:1512-1519.
21. Sullivan K: On the 'efficiency' of managed care plans Health Affairs 2000:139-148.
22. Gosden T, Pedersen L and Torgerson D: How should we pay doctors? A systematic review of salary payments and their effect on doctor behaviour Q J Med 1999, 92:47-55.
23. Jegers M, Kesteloot K, De Graeve D and Gilles W: A typology for provider payment systems in health care Health Policy 2002, 60(3):255-273.
24. Redmon P and Yakoboski P: The nominal and real effects of hospital budgets in France Inquiry 1995, 32:174-183.
25. Bloor K and Freemantle N: Lessons from international experience in controlling pharmaceutical expenditure II: influencing doctors British Medical Journal 1996, 312:1525-1527.
26. Schöffski O, Schulenberg JM and Graf von der: Unintended effects of a cost-containment policy: results of a natural experiment in Germany Social Science and Medicine 1997, 45(10):1537-1539.
27. European Observatory on Health Care Systems: Health Care Systems in Transition United Kingdom. WHO Copenhagen .
28. Brook H, Ware JE and Rogers WE et al.: Does free care improve adults' health? New England Journal of Medicine 1983, 309(23):1426-34.
29. Andersen R, Smedby B and Vagero D: Cost containment, solidarity and cautious experimentation: Swedish dilemmas Social Science and Medicine 2001, 52:1195-1204.
30. Zweifel P and Manning WG: Moral hazard and consumer incentives in health care In Handbook of Health Economics Volume 1A. Edited by: Culyer AJ, Newhouse JP. Amsterdam: North Holland; 2000:409-459.
31. Soumerai SB, McLaughlin TJ, Ross-Degnan D, Casteris CS and Bollini P: Effects of limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia New England Journal of Medicine 1994, 331:650-655.
32. OECD: OECD Health Data 2001 Comparative Analysis of 30 Countries Paris: OECD 2001.
33. Poullier JP: Administrative costs in selected industrialized countries Health Care Financing Review 1992, 13(4):167-172.
34. Ministry of Health and Welfare, Japan: Outline of Social Insurance in Japan Tokyo 1999.
35. Kass DI and Pautler PA: The administrative costs of non-profit health insurers Economic Inquiry 1981, 29(3):515-521.
36. Duriez M: Le système de santé en France Paris: Haut Comité de Santé Publique 2000.
37. Ikegami N and Campbell JC: Health care reform in Japan: The virtues of muddling through Health Affairs 1999, 18(3):56-75.
38. Freemantle N and Bloor K: Lessons from international experience in controlling pharmaceutical expenditure. I: influencing patients British Medical Journal 1996, 312:1469-1471.